Polyamine profiles in tumor, normal tissue of the homologous breast, blood, and urine of breast cancer sufferers

Breast Cancer Research and Treatment

Volumn 60, Issue 2, 2000, Pages 99-105

  Levêque, Jean ^a,b   Foucher, Fabrice ^a   Bansard, Jean Yves ^c   Havouis, Rene ^c   Grall, Jean Yves ^a   Moulinoux, Jacques Philippe ^c  

^a SERVICE DE RHUMATOLOGIE   (France)

^b UNIVERSITÉ DE RENNES 1   (France)

^c NONE

Author keywords

Breast cancer; Erythrocytes; Polyamines; Prognosis; Urine

Indexed keywords

ACETYLSPERMINE; KI 67 ANTIGEN; N1 ACETYLSPERMIDINE; N8 ACETYLSPERMIDINE; POLYAMINE; PUTRESCINE; SPERMIDINE; SPERMINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD LEVEL; BREAST CANCER; BREAST CARCINOGENESIS; BREAST DISEASE; CANCER INVASION; CONTROLLED STUDY; ERYTHROCYTE LEVEL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; POLYAMINE METABOLISM; PRIORITY JOURNAL; TISSUE LEVEL; URINE LEVEL;

ADENOCARCINOMA; AGED; BREAST DISEASES; BREAST NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; POLYAMINES;

EID: 0034030477     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006319818530     Document Type: Article

References (37)

1. 1. Pegg AE, McCann PP: Polyamine metabolism and function: a brief review. Am J Physiol 243: 212-221, 1982
2. 2. Jänne J, Pös H, Raina A: Polyamines in rapid growth and cancer. Biochim Biophys Acta 473: 241-293, 1978
3. 3. Pegg AE: Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 48: 759-774, 1988
4. 4. Kendra KL, Katzellenbogen BS: An evaluation of the involvement of polyamines in modulating MCF-7 human breast cancer cell proliferation and progesterone levels by estrogen and antiestrogen. J Steroid Biochem 28: 123-128, 1987
5. 5. Thomas T, Kiang DT: Additive growth-inhibitory effect of DL-α-adifluoromcthylornithine and antiestrogens on the MCF-7 breast cancer cell line. Biochem Biophys Res Commun 148: 1338-1345, 1987
6. 6. Glikman P, Manni A, Demers L, Bartholomew M: Polyamine involvement in the growth of hormone-responsive and -resistant human breast cancer cells in culture. Cancer Res 49: 1371-1376, 1989
7. 7. Manni A, Badger B, Martel J, Demers L: Role of polyamines on the growth of hormone-responsive and -resistant human breast cancer cells in nude mice. Cancer Lett 66: 1-9, 1992
8. 8. Kremmer T, Palyi I, Daubner D, Boldizsar M, Vincze B, Paulik E, Sugar J, Pokorny E, Tury E: Comparative studies on the polyamine metabolism and DFMO treatment of MCF-7 and MDA-MB-231 breast cancer cell lines and xenografts. Anticancer Res 11: 1807-1814, 1991
9. 9. Seiler N, Sarhan S, Graufel C, Jones R, Knodgen B, Moulinoux JP: Endogenous and exogenous polyamines in support to tumor growth. Cancer Res 50: 5077-5083, 1990
10. 10. Levêque J, Burtin F, Catros-Quemener V, Havouis R, Moulinoux J-P: The gastrointestinal polyamine source depletion enhances the DFMO induced polyamine depletion in MCF-7 human breast cancer in vivo. Anticancer Res 18: 2663-2668, 1998
11. 11. Azzopardi JG: Histological typing of breast tumors. WHO 1968 International Histological Classification of tumors. Geneva, 1981. Ann Pathol 2: 91-105, 1982
12. 12. Union Internationale Contre le Cancer (UICC): Tumeurs du sein. In: UICC (ed) TNM classification des tumeurs malignes. Springer Verlag, Paris, 1988, pp 99-106
13. 13. Bloom J, Richardson WW: Histological grading and prognosis in breast cancer. A study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11: 357-377, 1957
14. 14. Le Doussal V, Tubiana-Hulin M, Friedman S, Hacene K, Spyratos F, Brunet M: Prognostic value of histological grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas. Cancer 64: 1914-1921, 1989
15. 15. Hrushe WJM, Merdink J, Abdel-Monem A: Circadian rhythmicity of polyamine urinary excretion: Cancer Res 43: 3944-3947, 1983
16. 16. Seiler N: Separation of ion pairs of polyamines and related compounds on reversed phases. In: Kabra PM, Manon LJ (eds) Clinical Liquid Chromatography: Analysis of Endogenous Compounds. CRC Press, London, 1993, pp 179-187
17. 17. Shinpo K, Fujita K, Maruta K, Teradaira R, Nagatsu T: Comparative measurements of urinary polyamines in early morning and 24-hour urine specimens. Clin Chim Acta 131: 143-148, 1983
18. 18. Pöyhönen MJ, Uusitalo UM, Kari A, Takala JA, Alakuijula LA, Eloranta TO: Urinary excretion of polyamines: importance of circadian rhythm, age, sex, menstrual cycle, weight, and creatinine excretion. Am J Clin Nutr 52: 746-751, 1990
19. 19. Seiler N, Bolkenius FN, Rennert OM: Interconversion, catabolism and elimination of the polyamines. Med Biol 59: 334-346, 1981
20. 20. Suh JW, Lee SH, Chung BC, Park J: Urinary polyamine evaluation for effective diagnosis of various cancers. J Chromatog B 688, 179-186, 1997
21. 21. Cipolla B, Moulinoux JP, Quemener V, Havouis R, Martin L, Guillé F, Lobel B: Erythrocyte polyamine levels in human prostatic carcinoma. J Urol 144: 1164-1166, 1990
22. 22. Moulinoux JP, Quemener V, Le Calvé ML, Chatel M, Darcel F: Polyamines in human brain tumors: A correlative study between tumor, cerebrospinal fluid and red blood cell free polyamine levels. J Neuro-Oncol 2: 153-158, 1984
23. 23. Löser C, Fölsch UR, Paprotny C, Creutzfeldt W: Polyamines in colorectal cancer. Evaluation of polyamine concentrations in the colon tissue, serum, and urine of 50 patients with colorectal cancer. Cancer 65: 958-966, 1990
24. 24. Waalkes TP, Gehrke CW, Tormey DC, Zumwalt RW, Hueser IN, Kuo KC, Lakings DB, Ahmann DL, Moertel CG: Urinary excretion of polyamines by patients with advanced malignancy. Cancer Chemother Rep 59: 1103-1116, 1975
25. 25. Quemener V, Le Gall E, Edan C, Moulinoux JP: Red blood cell polyamine levels in children with acute leukemia: their clinical interest in disease staging and monitoring of therapy efficiency. Cancer J 4: 174-179, 1986
26. 26. Kingnorth AN, Wallace HM, Bundred NJ, Dixon JMJ: Polyamines in breast cancer. Br J Surg 71: 352-356, 1984
27. 27. Glikman P, Vegh I, Pollina MA, Mosto AH, Levy CM: Ornithine decarboxylase activity, prolactin blood levels, and estradiol and progesterone receptors in human breast cancer. Cancer 60: 2237-2243, 1987
28. 28. Manni A, Mauger D, Gimotty P, Badger B: Prognostic influence on survival of increased ornithine decarboxylase activity in human breast cancer. Clin Cancer Res 2: 1901-1906, 1996
29. 29. Marton LJ, Pegg AE: Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol 35: 55-91, 1995
30. 30. Manni A, Badger B, Lynch J, Glikman P, Demers L: Hormonal control of polyamine pools in experimental breast cancer in vivo: correlation with estrogen and progesterone receptor levels. Breast Cancer Res Treat 14: 227-234, 1989
31. 31. Thomas T, Thomas T: Estradiol control of ornithine decarboxylase mRNA, enzyme activity, and polyamine levels in MCF-7 breast cancer cells: therapeutic implications. Breast Cancer Res Treat 9: 189-201, 1993
32. 32. Manni A, Grove R, Kunzelman S, Aldaz M: Involvement of the polyamine pathway in breast cancer progression. Cancer Lett 92: 49-57, 1995
33. 33. Lu B, Liang X, Scott GK, Chang CH, Baldwin MA, Thomas T, Benz CC: Polyamine inhibition of estrogen receptor (ER) DNA-binding and ligand-binding functions. Breast Cancer Res Treat 48: 243-257, 1998
34. 34. Chanda R, Ganguly AK: Polyamines in relation to human breast cancer, rectal and squamous cell carcinoma. Cancer Let 39: 311-318, 1988
35. 1-acetylspermidine in human breast cancer. Cancer Let 45: 83-86, 1989
36. 36. Seiler N, Deleros JG, Moulinoux JP: Polyamine transport in mammalian cells. An update. Int J Biochem Cell Biol 28: 843-861, 1996
37. 37. Seiler N: Formation, catabolism and properties of the natural polyamines. In: Carter C (ed) The Neuropharmacology of Polyamines. Academic Press, London, 1994. pp 1-36